CIK 0001873835 · Pharmaceutical Preparations (SIC 2834) · Nasdaq · incorporated in DE · fiscal year ends 12/31
| FY2024 | FY2023 | FY2021 | |
|---|---|---|---|
| Net income (USD) | -15.4 M | -8.2 M | -24.4 M |
| Diluted EPS (USD/shares) | -0.89 | -0.59 |
| Filed | Form | Description | Period |
|---|---|---|---|
| 2026-09-30 | 8-K | 8-K items 8.01,9.01 | 2026-09-29 |
| 2026-09-29 | FWP | FWP | |
| 2026-09-29 | 424B5 | 424B5 | |
| 2026-09-29 | 8-K | 8-K items 7.01,8.01,9.01 | 2026-09-29 |
| 2026-08-14 | SCHEDULE 13G | SCHEDULE 13G | |
| 2026-08-13 | SCHEDULE 13G/A | SCHEDULE 13G/A | |
| 2026-08-07 | 10-Q | 10-Q | 2026-06-30 |
| 2026-07-20 | 8-K | 8-K items 8.01 | 2026-07-20 |
| 2026-06-05 | SCHEDULE 13G/A | SCHEDULE 13G/A | |
| 2026-05-29 | 8-K | 8-K items 5.07 | 2026-05-22 |
| 2026-05-29 | 4 | 4 | 2026-05-22 |
| 2026-05-29 | 4 | 4 | 2026-05-22 |
| 2026-05-29 | 4 | 4 | 2026-05-22 |
| 2026-05-29 | 4 | 4 | 2026-05-22 |
| 2026-05-29 | 4 | 4 | 2026-05-22 |
| 2026-05-29 | 4 | 4 | 2026-05-22 |
| 2026-05-29 | 4 | 4 | 2026-05-22 |
| 2026-05-29 | 4 | 4 | 2026-05-22 |
| 2026-05-29 | 4 | 4 | 2026-05-22 |
| 2026-05-21 | 8-K | 8-K items 8.01,9.01 | 2026-05-21 |
| 2026-05-21 | 424B5 | 424B5 | |
| 2026-05-21 | FWP | FWP | |
| 2026-05-21 | 8-K | 8-K items 7.01,8.01,9.01 | 2026-05-21 |
| 2026-05-15 | SCHEDULE 13G/A | SCHEDULE 13G/A | |
| 2026-05-07 | 10-Q | 10-Q | 2026-03-31 |
Forms on file (last 1,000): 4 81, 8-K 33, 10-Q 14, 3 12, 424B5 9, CORRESP 9, DEFA14A 6, UPLOAD 6. Source: SEC EDGAR, as filed; this page is public data and not investment advice.
GET https://store.agentexchange.work/gw/filings/company?ticker=IMMX (0.002 USD), /gw/filings/filings?ticker=IMMX&form=8-K, /gw/filings/facts?ticker=IMMX&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txtUpdated from EDGAR within 30 minutes of a filing. Agent Exchange